Results 71 to 80 of about 12,129 (222)

The Efficacy of Neoadjuvant Androgen Deprivation Therapy as a Prostate Volume Reduction before Brachytherapy for Clinically Localized Prostate Cancer [PDF]

, 2007
From September 2003 to December 2005, 188 patients who visited our hospital and allied institutions for the purpose of prostate brachytherapy were administrated hormonal therapy for volume reductions before brachytherapy.
Ebara, Shin, Hashine, Katsuyoshi, Kobayashi, Yasuyuki, Kumon, Hiromi, Manabe, Daisuke, Miki, Kenta, Nasu, Yasutomo, Saika, Takashi, Saito, Shirou, Satoh, Takefumi, Tanimoto, Ryuta   +10 more
core   +1 more source

Clinical test cases for commissioning, QA, and benchmarking of model‐based dose calculation algorithms in 1⁹2Ir HDR gynecologic tandem and ring brachytherapy

Medical Physics, Volume 53, Issue 1, January 2026.
Abstract Purpose To develop clinically relevant test cases for commissioning Model‐Based Dose Calculation Algorithms (MBDCAs) for 192Ir High Dose Rate (HDR) gynecologic brachytherapy following the workflow proposed by the TG‐186 report and the WGDCAB report 372.
Vasiliki Peppa, Maude Robitaille, Fatemeh Akbari, Shirin A. Enger, Rowan M. Thomson, Firas Mourtada, Gabriel P. Fonseca   +6 more
wiley   +1 more source

A survey on brachytherapy training of gynecological cancer focusing on the competence of residents in China

Radiation Oncology
Background The brachytherapy is an indispensable treatment for gynecological tumors, but the quality and efficiency of brachytherapy training for residents is still unclear.
Mohan Dong, Changhao Liu, Junfang Yan, Yong Zhu, Yutian Yin, Jia Wang, Ying Zhang, Lichun Wei, Lina Zhao   +8 more
doaj   +1 more source

Comparison of long-term prognoses between 3D-printed template-guided and conventional freehand interstitial brachytherapy for locally advanced cervical cancer: a single-center retrospective study

Frontiers in Oncology
ObjectiveConventional freehand three-dimensional interstitial brachytherapy (F-3DIB) for locally advanced cervical cancer (LACC) is limited by suboptimal dose distribution and operator dependency.
Jun-Jun Miao, Jun-Jun Miao, Jun-Jun Miao, Xu-Yu Zhang, Xu-Yu Zhang, Yong-Xia Zhang, Yong-Xia Zhang, Lei Gao, Lei Gao, Lu-Jun Zhao   +9 more
doaj   +1 more source

High-Dose Rate Salvage Interstitial Brachytherapy: A Case-Based Guide to the Treatment of Therapeutically Challenging Recurrent Vulvar Cancer

Frontiers in Oncology, 2017
Vulvar cancer is a rare gynecological malignancy with incidence rates steadily increasing over the past 10 years. Despite aggressive treatment, recurrent disease is common.
Kelly Eileen Hughes, Christopher M. McLaughlin, Emma C. Fields   +2 more
doaj   +1 more source

Treatment‐related changes in the prostate: past, present and future therapies

Histopathology, Volume 88, Issue 1, Page 40-52, January 2026.
Radiation therapy alters tumour morphology and immunoprofile in prostate cancer. Residual carcinoma shows distorted glandular architecture on H&E and loss of basal markers with preserved AMACR expression by immunohistochemistry, aiding in the recognition of treatment effect in prostate biopsies.
Katrina Collins, Liang Cheng
wiley   +1 more source

3D transformer-based dose prediction in HDR brachytherapy for cervical cancer

BMC Cancer
Background The clinical process of high-dose-rate brachytherapy (HDRBT) is time-consuming and relies on user expertise and preference. Deep learning-based dose prediction can act as a quality assurance (QA) tool to identify suboptimal needle placement ...
Weiwei Guo, Wanwei Jian, Lin Zhu, Bailin Zhang, Qiang He, Geng Yang, Xuetao Wang   +6 more
doaj   +1 more source

Treatment of hepatocellular carcinoma with gluteus medius metastasis: a case report and a literature review

Frontiers in Oncology
Hepatocellular carcinoma (HCC) accounts for 85%–90% of all primary liver cancers (PLCs). Owing to the occult nature of HCC, most patients present at an advanced stage at the time of initial diagnosis and have a poor prognosis.
Yanxin Li, Ji Luo, Jianyong Zhang, Mingqiang Sun, Jinping Yang   +4 more
doaj   +1 more source

NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. [PDF]

, 2017
PURPOSE: To determine the associated toxicity, tolerance, and safety of partial-breast reirradiation. METHODS AND MATERIALS: Eligibility criteria included in-breast recurrence occurring \u3e1 year after whole-breast irradiation, \u3c3 \u3ecm, unifocal ...
Arthur, Douglas W., Brown, Doris R., Canaday, Daniel J., Cohen, Randi J., Currey, Adam D., Cuttino, Laurie W., Fisher, Christine M., Haffty, Bruce G., Hayes, Shelly B., Jagsi, Reshma, Kuerer, Henry M., McCormick, Beryl, Sahijdak, Walter M., Simone, Nicole L., Todor, Dorin A., White, Julia, Winter, Kathryn A., Woodward, Wendy A.   +17 more
core   +1 more source

Ablative therapy for people with localised prostate cancer : a systematic review and economic evaluation [PDF]

, 2015
The research reported in this issue of the journal was funded by the HTA programme as project number 10/136/01. The contractual start date was in April 2012.
, , , Ahmed, Ahmed, Aitkenhead, Albertsen, Albertsen, Alemozaffar, Allen, Anandadas, Andriole, Arvold, Ashman, Bahn, Barret, Bart, Bayoumi, Bellardita, Beyer, Bhatnagar, Bill-Axelson, Blana, Blana, Boettcher, Boorjian, Borchers, Bosanquet, Bott, Bradley, Breyer, Brown, Bul, Burdick, Buron, Caso, Caso, Chamberlain, Chaussy, Chen, Chin, Ciezki, Coen, Cohen, Cohen, Cohen, Collins, Colombel, Cooperberg, Corwin, Cowen, Cox, Crook, Cytron, Dall’Era, Darras, De la Rosette, Dindo, Donnelly, Donnelly, Downs, Draisma, D’Amico, D’Amico, D’Amico, Eade, Eggener, El Fegoun, Elliott, Ellis, Epstein, Ferrer, Ficarra, Fourcade, Frank, Ganzer, Ganzer, Gardner, Gheiler, Giberti, Gleason, Godtman, Goldner, Goldner, Guedea, Hale, Han, Hardie, Heidenreich, Helpap, Hilton, Hoffmann, Hubosky, Hummel, Illing, Iman, Iman, Inoue, Ito, Jackson, Jani, Jemal, Johansson, Kattan, Kattan, Kibel, Kirschner-Hermanns, Klotz, Klotz, Klotz, Kobayashi, Kobuke, Koch, Korfage, Krahn, Kupelian, Lambert, Lane, Leal, Lee, Lee, Lepor, Lian, Lindner, Lindner, Litwin, Litwin, Loblaw, Mack, Maclennan, Maestroni, Malcolm, Marberger, Martinez, McNichols, Mearini, Merrick, Misrai, Mohamed, Mohammed, Neerhut, Nepple, Onik, Onik, Pardo, Paulson, Paulson, Pe, Pickles, Pinkawa, Pinthus, Poissonnier, Polascik, Potosky, Prentis, Rabbani, Ramsay, Raut, Reeve, Resnick, Roach, Robinson, Robinson, Robinson, Robinson, Ruchlin, Saliken, Salomon, Samaratunga, Sanda, Sandblom, Schroder, Seabra, Selvadurai, Shah, Shao, Shariat, Shelley, Shimizu, Shoji, Smith, Smith, Sobin, Sommers, Spiegelhalter, Stark, Stattin, Steginga, Stewart, Sumitomo, Sutton, Svatek, Svatek, Swartzman, Talcott, Tangen, Tefilli, Thompson, Thuroff, Tierney, Tosoian, Truesdale, Tsui, Uchida, Uchida, Uchida, Uchida, Uchida, Uchida, van As, van den Bergh, van den Bergh, van der Kwast, Van Der Poel, van Hout, Vasarainen, Vassil, Verhagen, Vicini, Vogl, Vose, Ward, Ware, Wei, Welch, Weldon, Williams, Wilt, Wong, Wong, Zelefsky, Zelefsky, Zeliadt, Zietman   +233 more
core   +3 more sources